Understanding the link between COVID-19, blood pressure and obesity: Perspectives from the New Orleans experience
- PMID: 39323904
- PMCID: PMC11423287
- DOI: 10.1016/j.ahjo.2024.100460
Understanding the link between COVID-19, blood pressure and obesity: Perspectives from the New Orleans experience
Keywords: Acute COVID-19; Clinical predictor of outcomes; Obesity; Pre-COVID hypertension; Systolic blood pressure.
Conflict of interest statement
Keith Ferdinand is an Editorial Board Member/Associate Editor for American Heart Journal plus and was not involved in the editorial review or the decision to publish this article. Arnaud Drouin and Dahlene Fusco declare the following financial interests/personal relationships which may be considered as potential competing interests: AD and DF have received investigator-initiated study awards from 10.13039/100005564Gilead Sciences, have served as site investigators for COVID-19 clinical trials sponsored by 10.13039/100005564Gilead, 10.13039/100009857Regeneron, and Metro Biotech LLC. DF has served on Advisory Boards for 10.13039/100005564Gilead Sciences and AXCELLA.
References
-
- Dahlene Fusco S.L., Theberge Marc, Pulapaka Anuhya S., Rittmeyer William, Zha Yitian, Marlowe Maylin W., Rothwell Ben, Adhikari Prateek, Raynaud Peter, Ferdinand Keith, Drouin Arnaud. MedRxiv; 2024. Admission Systolic Blood Pressure and Obesity Correlate With Fatal and Severe Acute COVID-19 in the Population of New Orleans, LA.
LinkOut - more resources
Full Text Sources
